A step towards gene therapy for CF.
Sansom
C
C
D017321:Clinical Trials, Phase I as Topic; D018849:Controlled Clinical Trials as Topic; D003550:Cystic Fibrosis / Q000503:physiopathology / Q000628:therapy*; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000235:genetics*; D004311:Double-Blind Method; D018014:Gene Transfer Techniques; D015316:Genetic Therapy / Q000379:methods*; D006801:Humans; D008081:Liposomes; D008168:Lung / Q000382:microbiology / Q000503:physiopathology; D008297:Male; D009297:Nasal Mucosa / Q000503:physiopathology; D016896:Treatment Outcome
C505032:CFTR protein, human; D008081:Liposomes; D019005:Cystic Fibrosis Transmembrane Conductance Regulator